By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Hogehilweg 7
1101 CA
Amsterdam Zuid-Oost      The Netherlands
Phone: 31-20-567-0900 Fax: 31-20-567-0999



Company News
Norgine Completes Acquisition Of Merus Labs (MSLI) Strengthening Its Leading Position In The European Specialist Pharma Market 7/18/2017 6:56:10 AM
Merus Labs (MSLI) Receives Court Approval In Connection With Proposed Plan Of Arrangement With Norgine 7/13/2017 6:59:52 AM
Merus Labs (MSLI) Shareholders Approve Plan Of Arrangement With Norgine 7/10/2017 9:55:51 AM
Merus Labs (MSLI) And Norgine Receive Spanish Anti-Trust Approval Of Proposed Arrangement 7/5/2017 10:24:25 AM
Merus Labs (MSLI) Mails Letter To Shareholders With Reminder To Vote For The Proposed Arrangement With Norgine By Deadline Of 10:00 AM (Toronto Time) July 6, 2017, And Receives Positive Recommendation In Favour Of The Arrangement From Independent Proxy Advisor ISS. 6/28/2017 7:36:30 AM
Merus Labs (MSLI) Files Management Information Circular For Proposed Acquisition By Norgine 6/6/2017 8:19:17 AM
Norgine Presents New Post-Hoc Data Analyses Highlighting The Efficacy Of PLENVU For Bowel Cleansing At DDW 5/8/2017 8:15:49 AM
Norgine And Noventure Enter Into An Agreement To Commercialise Gelsectan In Spain, Portugal And Andorra 3/6/2017 8:37:42 AM
Valeant (VRX) Announces Licensing Agreement With Norgine For NER1006 In U.S. And Canada 8/8/2016 6:55:18 AM
Norgine Release: New Positive Phase III Study For NER1006 - The First 1 Litre PEG-Based Bowel Preparation 5/24/2016 12:00:08 PM